14

Shares of British drug giant GlaxoSmithKline could suffer their worst one-day percentage drop in eight years, reports CNBCs Mike Huckman

CNBC interviews Jean-Pierre Garnier, chief of pharmaceutical giant GlaxoSmithKline, on the company's earnings decline from generic competition.

A look at the pharma giant's earnings forecast for the year ahead, with Jean-Pierre Garnier, GlaxoSmithKline CEO and CNBC's Mike Huckman

9125

...firms that vaccines are perfectly safe. This is one of the most critical questions facing today's children and future generations to come. If inoculation with a large regimen of vaccines is safe, ...

A battle royale begins over cervical cancer vaccines between Glaxo and Merck, with Mike Huckman, CNBC pharmaceuticals reporter